1.Metabolic syndrome and pulse wave velocity.
Kyung Mook CHOI ; Baik Sei HYUN
Korean Journal of Medicine 2005;68(2):130-132
No abstract available.
Pulse Wave Analysis*
2.A Case of Isolated ACTH Deficiency
Sang Jin KIM ; Kyung Mook CHOI ; Sei Hyun BAIK ; Dong Seop CHOI
Journal of Korean Society of Endocrinology 1995;10(4):445-450
solated ACTH deficiency is a very uncommon cause of hypoadrenocorticism, with less than 200 cases reported in the literatures. The clinical presentation can be similar to that of primary adrenal insufficiency, but there is a greater tendency for hypoglycemia and absence of hyperpigmentation. The diagnosis is established by demonstrating hypocortisolism with undetectable serum levels of ACTH, normal adrenal responsiveness to prolonged ACTH infusion, and an absent ACTH response to insulin-induced hypoglycemia. Other endocrine function is normal.We experienced a case of isolated ACTH deficiency in 34 years old female who was admitted due to fever and drowsy mentality.So we present this case with a review of literatures.
Addison Disease
;
Adrenocorticotropic Hormone
;
Diagnosis
;
Female
;
Fever
;
Humans
;
Hyperpigmentation
;
Hypoglycemia
3.Non-alcoholic Fatty Liver Disease and Adiponectin.
Korean Diabetes Journal 2008;32(2):98-101
No abstract available.
Adiponectin
;
Fatty Liver
4.Coronary Artery Disease and Retinol Binding Protein 4.
Korean Diabetes Journal 2009;33(2):91-93
No abstract available.
Carrier Proteins
;
Coronary Artery Disease
;
Coronary Vessels
;
Vitamin A
5.Corticosteroid Therapy for Adrenal Insufficiency.
Journal of the Korean Academy of Family Medicine 2003;24(1):1-5
No abstract available.
Adrenal Insufficiency*
7.Effect of ondansetron in prevention of nausea and vomiting associated with cisplatin chemothrapy in cancer patients.
Sang Won SHIN ; Kyung Mook CHOI ; Jong Eun YUN ; Sang Myun PARK ; Chul Won CHOI ; Joon Suk KIM
Journal of the Korean Cancer Association 1993;25(2):299-306
No abstract available.
Cisplatin*
;
Humans
;
Nausea*
;
Ondansetron*
;
Vomiting*
8.Sequential Changes of Chest Radiographic Finding after Exogenous Surfactant Replacement Therapy in Neonates with RDS.
Hyeok CHOI ; Chong Woo BAE ; Sa Jun CHUNG ; Yong Mook CHOI
Journal of the Korean Pediatric Society 1995;38(2):151-158
PURPOSE: The chest radiograph is useful and reliable in assessing the severity and progression of neonatal respiratory distress syndrome. To evaluate the effect of exogenous surfactant r eplacement therapy, we performed sequential observation of chest radiogratphic findings in neonates with respiratory distress syndrome. METHODS: Two groups of infant with RDS in mechanical ventilation therapy were studied. Surfactant(S-Tx) group(n=36) was treated with Surfactant-TA and control group(n=19) was without use of surfactant. Observation of gestational age, birth weight, clinical severity by ventilatory index, sequential change of radiographic findings and radiological complications in RDS patients were performed. RESULTS: In RDS patients, there was correlation in the radiologic grading and clinical severity. In surfactant treated infants, change of chest radiographic finding was significantly improved than control group. Incidence of pneumothorax and or pulmonary interstial emphysema in S-Tx group was less than that of control group. CONCLUSIONS: Exogenous pulmonary surfactant replacement therapy may contribute the improvement of the clinical and radiological severity and reduction of the incidence of clinical complications. We suggest that surfactant replacement therapy is effective and important useful therapeutic method in neonates with respiratory distress syndrome.
Birth Weight
;
Emphysema
;
Gestational Age
;
Humans
;
Incidence
;
Infant
;
Infant, Newborn*
;
Pneumothorax
;
Pulmonary Surfactants
;
Radiography, Thoracic*
;
Respiration, Artificial
;
Respiratory Distress Syndrome, Newborn
;
Thorax*
9.Hepatokines as a Link between Obesity and Cardiovascular Diseases.
Diabetes & Metabolism Journal 2015;39(1):10-15
Non-alcoholic fatty liver disease, which is considered a hepatic manifestation of metabolic syndrome, independently increases the risks of developing cardiovascular disease (CVD) and type 2 diabetes mellitus. Recent emerging evidence suggests that a group of predominantly liver-derived proteins called hepatokines directly affect the progression of atherosclerosis by modulating endothelial dysfunction and infiltration of inflammatory cells into vessel walls. Here, we summarize the role of the representative hepatokines fibroblast growth factor 21, fetuin-A, and selenoprotein P in the progression of CVD.
alpha-2-HS-Glycoprotein
;
Atherosclerosis
;
Cardiovascular Diseases*
;
Diabetes Mellitus, Type 2
;
Fatty Liver
;
Fibroblast Growth Factors
;
Obesity*
;
Selenoprotein P